Response to article by Johnna Perdrizet et al.,"Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants".
Saved in:
| Title: | Response to article by Johnna Perdrizet et al.,"Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants". |
|---|---|
| Authors: | Gómez JA; Vaccine Department, GlaxoSmithKline, Buenos Aires, Argentina., Pinto TJP; Vaccine Department, GlaxoSmithKline, Rio de Janeiro, Brazil., Guevara JN; Vaccine Department, GlaxoSmithKline, Panama City, Panama., Noronha TG; Institute of Technology for Immunobiologicals of Bio-Manguinhos, FIOCRUZ, Rio de Janeiro, Brazil. |
| Source: | Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1894898. Date of Electronic Publication: 2021 May 19. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2164-554X |
|---|---|
| DOI: | 10.1080/21645515.2021.1894898 |
